Machine learning and artificial intelligence are valuable tools that can help in the development of immuno modulators for respiratory infections, such as influenza and COVID-19. These technologies can analyze large amounts of data and identify patterns and relationships that are difficult for humans to detect, accelerating the drug discovery and development process. Immuno modulators can enhance the immune system's response to respiratory infections, but the traditional drug development process can be time-consuming, expensive, and have a high rate of failure. By leveraging machine learning and AI, researchers can identify and optimize drug candidates more quickly and efficiently, ultimately leading to better outcomes for patients and improving public health

Artificial Intelligence in Drug Discovery